Amino Acids, Heart Disease and Blood Pressure: Arginine, Citrulline, Taurine, Glycine and Carnitine
What trials and reviews show for arginine, citrulline, taurine, glycine and carnitine on blood pressure and heart disease, separating blood pressure readings from heart outcomes, plus safety points.
Content last updated . This page has not been medically reviewed.
Urgent first
Sudden chest pain that does not go away, pain spreading to the arm, neck, jaw, stomach or back, or chest pain with sweating, sickness, light-headedness or breathlessness could be a heart attack. The UK NHS says to call 999 straight away and not to drive yourself to A&E. [1] In the US, call 911.Start here
This page is information only. High blood pressure and heart disease are managed with a clinician. The NHS says a GP will usually prescribe blood pressure medicine if blood pressure is very high, if there is higher risk of heart attack or stroke, or if it stays high after lifestyle changes. [1] Do not replace or stop a prescribed medicine for an amino acid product. Tell your pharmacist and doctor about every supplement; see Medication Interactions.How to read the evidence on this page
We label findings as "surrogate" (blood pressure or cholesterol readings), "clinical outcome" (heart attacks, deaths, hospital stays), "mixed", "limited" (small or few trials), "evidence of harm" and "Proper evidence not found". A lower blood pressure number in a short trial does not prove fewer heart attacks. "Study amount" means the dose a trial used, never advice.Where each amino acid sits
Classification matters. MedlinePlus lists arginine and glycine among the conditionally essential amino acids (usually not essential, except in times of illness and stress). [2] A 2023 review of upper intake levels calls arginine nonessential and citrulline nonproteinogenic (not used to build proteins). [3] A 2026 review describes taurine as a non-proteinogenic amino acid. [4] We did not find a classification source for carnitine among the pages read for this page. Each compound has its own page: Arginine and Citrulline, Taurine, Carnitine and Glycine.Evidence table
| Compound and group | What the source found (study amounts) | Evidence label |
|---|---|---|
| Arginine, adults, 11 placebo-controlled trials (387 people), 4 to 24 g/day, 2011 meta-analysis | Systolic BP lower by 5.39 mm Hg and diastolic by 2.66 mm Hg versus placebo [5] | Surrogate; small trials |
| Arginine, adults, 22 trials, 2022 meta-analysis | Systolic BP lower by 6.40 mm Hg and diastolic by 2.64 mm Hg; no significant change at doses above 9 g/day or in obese people [6] | Surrogate; mixed by subgroup |
| Arginine after a first heart attack (153 people, 6 months) | No change in vascular stiffness or ejection fraction, and 6 deaths (8.6%) in the arginine group versus none with placebo [7] | Clinical outcome; evidence of harm in this group |
| Citrulline, adults, 5 interventions, 2018 meta-analysis | No significant change in brachial or aortic blood pressure [8] | Surrogate; no effect found |
| Citrulline, adults, 8 trials (12 to 34 people each), 2019 meta-analysis | Systolic BP lower by about 4.1 mm Hg; diastolic change not significant overall [9] | Surrogate; mixed with the 2018 result |
| Citrulline or watermelon, middle-aged and older adults, 15 trials, 2025 meta-analysis | Systolic BP lower by about 4.0 mm Hg [10] | Surrogate; combines different products |
| Taurine, 12 trials, mostly people with liver or metabolic problems, 0.5 to 6 g/day for 15 days to 6 months, 2020 | Systolic BP lower by about 4.7 mm Hg, diastolic about 2.9, plus total cholesterol and triglycerides [11] | Surrogate; limited, specific groups |
| Taurine, 25 trials (1024 people), 2024 | Lower systolic and diastolic BP, fasting glucose and triglycerides; no significant adverse effects seen [12] | Surrogate; limited |
| Carnitine after a heart attack, 5 controlled trials (3108 people) | The authors' background says carnitine has been associated with lower all-cause mortality, ventricular arrhythmia and angina after a heart attack; their dosage comparison found no significant difference between four daily oral amounts on deaths or heart failure [13] | Clinical outcome; dose comparison only |
| Carnitine in heart failure, evidence map of 122 trials across 14 interventions, 2021 | Moderate certainty of benefit on left ventricular ejection fraction [14] | Surrogate (a heart pumping measure) |
| Glycine and blood pressure or heart disease | Proper evidence not found. We searched PubMed for glycine with cardiovascular or blood pressure trials and found nothing we could use | None |
What the table does and does not show
- Blood pressure drops are surrogate findings. The arginine and citrulline meta-analyses measured blood pressure, and the trials were small, short and varied in dose. The arginine meta-analysis also reported similar results in trials where participants did not use blood pressure medicines. [5]
- Where a clinical outcome was tested, the arginine result was a warning. The post-heart-attack trial concluded that L-arginine should not be recommended after acute myocardial infarction. [7]
- Carnitine has a separate safety question. Gut bacteria turn dietary carnitine into trimethylamine, which the liver converts to TMAO, and a review discussed whether this might raise cardiovascular risk, alongside benefits for metabolism. [15] The review presents this as a postulated concern, so evidence is unsettled; see L-Carnitine for Heart, Fertility, Exercise and Weight.
- Evidence for taurine comes from people with liver or metabolic disease and short trials; see Taurine, Energy Drinks, Heart Health and Longevity.
For the focused arginine and citrulline summary see Arginine, Citrulline, Nitric Oxide and Blood Pressure.
Related
Amino Acids & Protein · Protein FoundationsFrequently asked questions
Does arginine lower blood pressure?
Two meta-analyses of small trials found lower readings (about 5 to 6 mm Hg systolic), but these are surrogate findings, and effects varied by dose and group. [5][6]
Is arginine safe after a heart attack?
A randomized trial in 153 people found no benefit and more deaths with arginine, and concluded it should not be recommended after a heart attack. [7] Ask your cardiology team.
Does citrulline work for blood pressure?
Reviews disagree: one found no significant change, another found a lowering of systolic pressure. [8][9]
Does taurine help the heart?
Trials in specific groups lowered blood pressure and lipids, but evidence for heart attacks or deaths was not found in the reviews we read. [11]
Does glycine help blood pressure or heart disease?
Proper evidence not found; we searched PubMed for glycine, blood pressure and cardiovascular trials.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Safety
- Blood pressure and heart medicines: these products lowered blood pressure in trials, so anyone taking blood pressure, nitrate or other heart medicines should ask a pharmacist before using them. The sources we read do not give a full list of documented interactions, so we do not claim one.
- After a heart attack, with heart failure or an arrhythmia: do not self-treat with arginine; see the trial above.
- Pregnancy and breastfeeding: a 2025 review found, in prevention trials, that arginine was associated with a reduced risk of pre-eclampsia on low-certainty evidence. [16] That is a clinical-care topic and not a basis for self-treatment; see Pregnancy and Breastfeeding.
- Kidney and liver disease, children, older adults: the sources we read give no reassurance for these groups; ask a clinician.
- Surgery: see Supplements Before Surgery.
- Quality: see Quality Testing and Certifications and Pre-Workout and Energy Drink Amino Acid Blends.
References
- NHS (UK). High blood pressure (hypertension). Read 2026-10-23.
- MedlinePlus (US National Library of Medicine). Amino acids. Review date 1/21/2025. Read 2026-10-23.
- Tolerable Upper Intake Level for Individual Amino Acids in Humans: A Narrative Review of Recent Clinical Studies. Advances in Nutrition 2023 (PubMed abstract). Read 2026-10-23.
- Taurine supplementation at the crossroads of metabolism, inflammation and aging: mechanistic and nutritional perspectives. Food & Function 2026 (PubMed abstract). Read 2026-10-23.
- Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials. American Heart Journal 2011 (PubMed abstract). Read 2026-10-23.
- Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials. Advances in Nutrition 2022 (PubMed abstract). Read 2026-10-23.
- Schulman SP, et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 2006 (PubMed abstract). Read 2026-10-23.
- Effect of L-Citrulline Supplementation on Blood Pressure: a Systematic Review and Meta-Analysis of Clinical Trials. Current Hypertension Reports 2018 (PubMed abstract). Read 2026-10-23.
- Effects of L-citrulline supplementation on blood pressure: A systematic review and meta-analysis. Avicenna Journal of Phytomedicine 2019 (PubMed abstract). Read 2026-10-23.
- Does l-citrulline supplementation and watermelon intake reduce blood pressure in middle-aged and older adults? A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 2025 (PubMed abstract). Read 2026-10-23.
- The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. European Journal of Pharmacology 2020 (PubMed abstract). Read 2026-10-23.
- Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Nutrition & Diabetes 2024 (PubMed abstract). Read 2026-10-23.
- Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis. BMC Cardiovascular Disorders 2014 (PubMed abstract). Read 2026-10-23.
- Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map. European Journal of Heart Failure 2021 (PubMed abstract). Read 2026-10-23.
- Gut microbiota metabolism of L-carnitine and cardiovascular risk. Atherosclerosis 2013 (PubMed abstract). Read 2026-10-23.
- L-Arginine and L-Citrulline for Prevention and Treatment of Pre-Eclampsia: A Systematic Review and Meta-Analysis. BJOG 2025 (PubMed abstract). Read 2026-10-23.